CinRx Pharma
Cincinnati, Ohiocinrx.com
Overview
CinRx Pharma is a biopharmaceutical company that utilizes a hub-and-spoke business model to license or acquire promising medical compounds and build specialized portfolio companies, known as 'CinCos,' to advance therapies through clinical development.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CinDome Pharma | Jun 2025 | VC Round | Co-investor |
| CinDome Pharma | May 2024 | Series B Extension | Co-investor |
| CinDome Pharma | Apr 2023 | Series B | Co-investor |
| CinDome Pharma | - | VC Round | Co-investor |
Key People
Jonathan Isaacsohn
CEO
Mackenzie L. Pater
Interim Head of Clinical Operations, Executive Director, Portfolio Management
Dalia Levine
Senior Director, CMC
B.J. Privett
Director of CMC
Elizabeth Moriarity
Director Of Clinical Monitoring
William Tracewell
Sr. Director, Clinical Pharmacology
Yuan Lu
Director, Toxicology
Jason Westerheide
Chief Business Officer
Mary Bond
Chief Translational Science Officer
Sally Dressman
Chief Administrative Officer
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?